Skip to main content

Olink Holding AB (publ) (OLK)

NASDAQ: OLK · Delayed Price · USD
28.41 -0.62 (-2.14%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap3.38B
Revenue (ttm)69.50M
Net Income (ttm)n/a
Shares Out119.01M
EPS (ttm)-0.37
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume156,013
Open29.14
Previous Close29.03
Day's Range27.54 - 30.49
52-Week Range25.55 - 42.20
Betan/a
Analystsn/a
Price Target43.00 (+51.4%)
Est. Earnings DateNov 11, 2021

About OLK

Our purpose is to enable and accelerate the field of proteomics by providing a platform of products and services that are deployed across major biopharmaceutical companies and leading clinical and academic institutions, to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. We support 30 of the world’s largest 40 biopharmaceutical companies by 2019 revenue, including all of the largest 19, and many leading academic institutions. Our current offering is based on our pr...

IndustryDiagnostics & Research
IPO DateMar 25, 2021
CEOJon Heimer
Employees214
Stock ExchangeNASDAQ
Ticker SymbolOLK
Full Company Profile

Financial Performance

In 2020, Olink Holding's revenue was $54.07 million, an increase of 29.68% compared to the previous year's $41.69 million. Losses were -$6.78 million, -62.08% less than in 2019.

Financial Statements

News

Olink to present at two upcoming investor conferences

UPPSALA, Sweden, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual...

2 weeks ago - GlobeNewsWire

CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services

UPPSALA, Sweden, Aug. 31, 2021 (GLOBE NEWSWIRE) -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech custome...

2 weeks ago - GlobeNewsWire

Olink reports second quarter 2021 financial results

UPPSALA, Sweden, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its financial results for the second quarter of 2021.

1 month ago - GlobeNewsWire

Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for ...

UPPSALA, Sweden, July 27, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB ( publ ) (“Olink”) (Nasdaq: OLK) today announced t h at CORAL, a new collaborative community of scientists , will use the Olink Proteo...

1 month ago - GlobeNewsWire

UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072

UPPSALA, Sweden, July 21, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the UK Biobank Pharma Proteomics Project (UKB-PPP Consortium) has decided to expand the ongo...

1 month ago - GlobeNewsWire

Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders

UPPSALA, Sweden, July 15, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 7,500,000 American Depositary Sha...

2 months ago - GlobeNewsWire

Why Olink Shares Are Getting Hammered Today

Olink Holding AB (publ) – ADR (NASDAQ:OLK) shares are trading lower by 11% at $31.94 after the company announced a public offering of 7 million ADSs by selling shareholders. Olink Holding AB has a propr...

2 months ago - Benzinga

Olink announces preliminary financial results for the second quarter 2021

UPPSALA, Sweden, July 12, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB ( publ ) (“Olink”) (Nasdaq: OLK) today announce d preliminary unaudited revenue and net income (loss) for the second quarter ended Jun...

2 months ago - GlobeNewsWire

Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders

UPPSALA, Sweden, July 12, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the launch of a public offering of 7,000,000 American Depositary Shar...

2 months ago - GlobeNewsWire

Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling

UPPSALA, Sweden, June 15, 2021 (GLOBE NEWSWIRE) --  Scallop-logo-470-pxOlink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the SCALLOP consortium (Systematic and Combined AnaLysis of Ol...

3 months ago - GlobeNewsWire

Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedic...

UPPSALA, Sweden, June 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink® Signature Q100, to allow more researchers access to Olink...

3 months ago - GlobeNewsWire

Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference

UPPSALA, Sweden, May 25, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it will be participating in the Goldman Sachs 42nd Annual Global Healthcare Confere...

3 months ago - GlobeNewsWire

Olink reports first quarter 2021 financial results and issues full year 2021 guidance

UPPSALA, Sweden, May 20, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its financial results for the first quarter of 2021.

3 months ago - GlobeNewsWire

Olink to Report First Quarter 2021 Financial Results on May 20, 2021

UPPSALA, Sweden, April 29, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, today announced that it will release financial results for the first quarter of...

4 months ago - GlobeNewsWire

Olink Holding AB (publ) Announces Pricing of Initial Public Offering

Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of its...

5 months ago - GlobeNewswire

Swedish proteomics platform Olink files for a $100 million US IPO

Olink Holding, which provides a platform of proteome analysis products for biomedical research, filed on Wednesday with the SEC to raise up to $100 million in a US initial public offering.

6 months ago - NASDAQ

Olink Holding IPO Registration Document (S-1)

Olink Holding AB (publ) has filed to go public with an IPO on the NASDAQ.

6 months ago - SEC